,outcome,arm 1,arm 2
0,intervention,,doxorubicin patients
0,Protocol-defined cardiotoxicity,NR,"29 % of, 9 cases, CHF )"
0,"Protocol-defined cardiotoxicity, total study group","13 % of TLC D-99, 2 cases","13 % of TLC D-99, 2 cases"
